Tianjin Ringpu Bio-Technology Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 533.2 million compared to CNY 442.78 million a year ago. Revenue was CNY 533.2 million compared to CNY 442.78 million a year ago.

Net income was CNY 87.57 million compared to CNY 80.82 million a year ago. Basic earnings per share from continuing operations was CNY 0.1901 compared to CNY 0.1742 a year ago. Diluted earnings per share from continuing operations was CNY 0.1901 compared to CNY 0.1742 a year ago.